Johnson & Johnson and Genmab both used the festive period to junk therapies that haven’t lived up to their promise in the clinic. J&J had been evaluating JNJ-95475939, an inhibitor of IL-4 and IL-31, ...
Hosted on MSN
Top 4 Canadian biotech stocks of 2025
Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to companies pursuing cutting-edge therapies and medical ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Pipeline and key clinical candidates for these companies: ...
Add Yahoo as a preferred source to see more of our stories on Google. If you’re a Stranger Things fan who still needs to watch Volume 1 of Season 5 before Volume 2 drops this week, but you need a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback